In Vitro Activity and MIC of Sitafloxacin against Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis Isolated in Thailand

New fluoroquinolones (FQs) have been shown to be more active against drug-resistant Mycobacterium tuberculosis strains than early FQs, such as ofloxacin. Sitafloxacin (STFX) is a new fluoroquinolone with in vitro activity against a broad range of bacteria, including M. tuberculosis. This study aimed...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Antimicrob Agents Chemother
Hlavní autoři: Leechawengwongs, Manoon, Prammananan, Therdsak, Jaitrong, Sarinya, Billamas, Pamaree, Makhao, Nampueng, Thamnongdee, Nongnard, Thanormchat, Arirat, Phurattanakornkul, Arisa, Rattanarangsee, Somcharn, Ratanajaraya, Chate, Disratthakit, Areeya, Chaiprasert, Angkana
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2017
Témata:
Susceptibility
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5740303/
https://ncbi.nlm.nih.gov/pubmed/29061759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00825-17
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky